The Prevalence of Helicobacter Pylori Infection in Patients with Chronic Kidney Disease Undergoing Hemodialysis

1. Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA 2019; 322(13):1294–304.10.1001/jama.2019.14745701567031573641 Search in Google Scholar

2. Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017; 2(2): e000380.10.1136/bmjgh-2017-000380571794829225940 Search in Google Scholar

3. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395: 709–33. Search in Google Scholar

4. Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl 2017; 7(2): 122–9.10.1016/j.kisu.2017.07.007634100730675426 Search in Google Scholar

5. Kızıltaş Ş, Şahin S. Upper gastrointestinal disorders among dialysis patients. ACU Sağlık Bil Derg 2019; 10(2):135–41. Search in Google Scholar

6. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J-R, et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130(5): 1466–79.10.1053/j.gastro.2005.11.05916678560 Search in Google Scholar

7. Ariffin NFM, Naing L, Pisharam J, Khalil MAM, Tamin N, Chong VH, et al. Appetite and gastrointestinal symptoms in end stage renal disease patients. J Clin Exp Nephrol 2016; 1(2): 1–6. Search in Google Scholar

8. Lisowska-Myjak B: Uremic toxins and their effects on multiple organ systems. Nephron Clin Pract 2014; 128: 303–11.10.1159/00036981725531673 Search in Google Scholar

9. Broberg B, Madsen JL, Fuglsang S, Holst JJ, Christensen KB, Rydahl C, et al. Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis. Neurogastroenterol Motil 2019; 31(4): e13554.10.1111/nmo.1355430667131 Search in Google Scholar

10. Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, and Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis. 2016; 9: 319–28.10.2147/IJNRD.S84784515326627994478 Search in Google Scholar

11. Turshudzhyan A, Inyangetor D. Uremic and post-transplant gastropathy in patients with chronic kidney disease and end-stage renal disease. Cureus 2020; 21; 12(9): e10578.10.7759/cureus.10578751050932983742 Search in Google Scholar

12. Sugimoto M, Yasuda H, Andoh A. Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis. World J Gastroenterol 2018; 24(15): 1591–600.10.3748/wjg.v24.i15.1591591054229686466 Search in Google Scholar

13. Khedmat H, Ahmadzad-Asl M, Amini M, Lessan-Pezeshki M, Einollahi B, Pourfarziani V, et al. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc 2007; 39(4): 1003–7.10.1016/j.transproceed.2007.03.03417524875 Search in Google Scholar

14. Ji Yong Ahn. Prevalence of Helicobacter pylori infection in patients with chronic kidney disease. Gut Liver 2019; 13(6): 585–6.10.5009/gnl19310686003131724387 Search in Google Scholar

15. Abdulrahman IS, Al-Mueilo SH, Ismail MH, Yasawy MI, Al-Qahtani FN, Al-Qorain AA. Does helicobacter pylori infection in chronic renal failure increase the risk of gastroduodenal lesions? A prospective study. Saudi J gastroenterol 2004; 10(2): 78–85. Search in Google Scholar

16. Usta M, Ersoy A, Ayar Y, Ocakoğlu G, Yuzbasioglu B, Erdem ED, Erdogan O. Comparison of endoscopic and pathological findings of the upper gastrointestinal tract in transplant candidate patients undergoing hemodialysis or peritoneal dialysis treatment: a review of literature. BMC Nephrol 2020; 21:444–52.10.1186/s12882-020-02108-w758322633092560 Search in Google Scholar

17. Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005;18: 643–50.10.1111/j.1432-2277.2005.00134.x15910287 Search in Google Scholar

18. Santos PR, Monteiro DL, de Paula PH, Neto VL, Monte Coelho ML, Arcanjo CC, et al. Volaemic status and dyspepsia in end-stage renal disease patients. Nephrology (Carlton) 2015; 20: 519–22.10.1111/nep.1248125854288 Search in Google Scholar

19. Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 2006; 15(3): 237–41. Search in Google Scholar

20. Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int 2009; 75: 96–103.10.1038/ki.2008.508312691618843261 Search in Google Scholar

21. Chang WC, Jo Y-I, Park H-S, Jegal J, Park J-H, Lee JH, et al. Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patient. Clin Exp Nephrol 2010; 14: 469–73.10.1007/s10157-010-0319-720632062 Search in Google Scholar

22. Kaneko H, Konagaya T, Kusugami K. Helicobacter pylori and gut hormones. J Gastroenterol 2002; 37(2): 77–86.10.1007/s00535020000011871770 Search in Google Scholar

23. Junior, LDS, Santos PR, dos Santos AA, Henrique M, de Souza LP. Dyspepsia and gastric emptying in end-stage renal disease patients on hemodialysis. BMC Nephrol 2013; 14: 275.10.1186/1471-2369-14-275386741724330675 Search in Google Scholar

24. Huang Y, Wang Q, Cheng D, Xu W, and Lu N. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori. Front Cell Infect Microbiol 2016; 6:159.10.3389/fcimb.2016.00159511884727921009 Search in Google Scholar

25. Aydemir S, Ozdemir BH, Gurg G, Dogan I, Yilmaz U, Boyacioglu S. Effects of Helicobacter pylori infection on gastric epithelial cell kinetics in patients with chronic renal failure. World J Gastroenterol 2005; 11(45): 7183–7.10.3748/wjg.v11.i45.7183472509116437669 Search in Google Scholar

26. Wijarnpreecha K, Thongprayoon C, Nissaisorakarn P, Lekuthai N, Jaruvongvanich V, Nakkala K, et al. Association betwwen Helicobacter pylori and end-stage renal disease: A meta-analysis. World J Gastroenterol 2017; 23(8): 1497–506.10.3748/wjg.v23.i8.1497533083528293097 Search in Google Scholar

27. Nakajima F, Sakaguchi M, Oka H, Kawase Y, Shibahara N, Inoue T, et al. Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology (Carlton) 2004; 9: 73–6.10.1111/j.1440-1797.2004.00239.x15056265 Search in Google Scholar

28. Karn W, Charat T, Pichaphon N, et al. Association of Helicobacetr pylori with chronic kidney diseases: a meta-analysis. 2017 Springer, Berlin. Search in Google Scholar

29. Li KJ, Chen L. Association between duration of dialysis and Helicobacter pylori infection in dialysis patients: a meta-analysis. Int Urol Nephrol 2019; 51(8): 1361–70.10.1007/s11255-019-02205-231214954 Search in Google Scholar

30. Nakajima F, Sakaguchi M, Amemoto K, Oka H, Kubo M, Shibahara N, et al. Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol 2002; 22: 468–72.10.1159/00006527812381945 Search in Google Scholar

31. Rasmi Y, Farshid S, Makhdomi K. Effect of duration on hemodialysis on prevalence of Helicobacter pylori infection. Saudi J Kidney Dis Transplant 2012; 23: 489–92. Search in Google Scholar

32. Itatsu T, Miwa H, Nagahara A, Kubota M, Miyazaki A, Sato N, Hayashida Y. Eradication of Helicobacter pylori in hemodialysis patients. Renal Failure 2007; 29: 97–102.10.1080/0886022060103912217365917 Search in Google Scholar

33. Watanabe H, Hiraishi H, Ishida M, Kazama J, Terano A. Pathophysiology of gastric acid secretion in patients with chronic renal failure: influence of Helicobacter pylori infection. J Intern Med 2003; 254(5): 439–46.10.1046/j.1365-2796.2003.01210.x14535965 Search in Google Scholar

34. Sahara S, Sugimoto M, Ichikawa H, Kagami T, Sakao Y, Ohashi N, et al. Efficacy of reduced dosage of amoxicillin in an eradication therapy for Helicobacter pylori infection in patients on hemodialysis: A randomized controlled trial. Digestion 2018; 97(2): 163–9.10.1159/00048498129310119 Search in Google Scholar